Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001258693-26-000010

CHIEF EXECUTIVE OFFICER sold 24,461 shares at an average $52.50 ($1,284,205)

  • CHIEF EXECUTIVE OFFICER acquired 225 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2026-06-18 Option exercise 10b5-1 +225 $1.79 $403 497,164 D: show line 1 in the form
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2026-06-18 Sale 10b5-1 −225 $52.51 $11,815 496,939 D: show line 2 in the form
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2026-06-18 Sale 10b5-1 −22,236 $52.50 $1,167,390 474,703 D: show line 3 in the form
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2026-06-18 Sale 10b5-1 −1,000 $52.50 $52,500 135,215 I: show line 4 in the form
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2026-06-18 Sale 10b5-1 −1,000 $52.50 $52,500 135,215 I: show line 5 in the form
Open-market sales · 24,461 sh · avg $52.50 · $1,284,205

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
PICKERING GRANT CHIEF EXECUTIVE OFFICER 2026-06-18 Option exercise · Stock Option (right to buy) 10b5-1 −225 0 D: show line 6 in the form
Loading xslF345X06/wk-form4_1781827692.xml…